EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incorporating Next-Generation Sequencing in Newborn Screening for Organic Acidemias

Yiming Lin iD, Jinping Zhong, Weilin Peng, Faming Zheng, Xudong Wang iD

International Journal of Neonatal Screening · 19.03.2026 · 12 (1) · 18

DOI: 10.3390/ijns12010018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 19.03.2026. Verfasst von Yiming Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Maternity and Children's Hospital, School of Medicine, Huaqiao University, Quanzhou 362021, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds for the Innovation of Science and Technology, Fujian province, Quanzhou Municipal Science and Technology Plan Project, Fujian Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organic acidemias (OADs) are a group of inherited metabolic disorders with a high false-positive rate in newborn screening. In this study, we aimed to evaluate the clinical performance of next-generation sequencing (NGS) as a combined genetic test for OADs. From September 2022 to August 2025, 154,634 newborns underwent primary screening using tandem mass spectrometry (MS/MS). Among them, 151 neonates with suspected OADs underwent combined genetic screening using a pre-designed NGS panel. Of these, 55 cases tested positive on genetic screening, and 17 were ultimately diagnosed with OADs, yielding a prevalence of 1 in 9096. The positive predictive value of NGS was 30.91% (17/55). The genotypes of nine patients (9/17, 52.9%) were identified through NGS screening. Notably, one case of methylmalonic acidemia that would have been missed by MS/MS screening was successfully identified using the combined genetic screening. Additionally, 37 neonates with positive biochemical screening results were confirmed to be either carriers or unaffected individuals. Two cases of Wilson’s disease were also identified through combined genetic screening. Therefore, integrating NGS into conventional MS/MS-based screening can significantly reduce the false-positive rate and shorten the time from screening to definitive diagnosis. This approach provides a valuable model for improving the efficiency and accuracy of newborn genetic screening.

Schlagwörter

Stichwörter der Autor:innen

combined genetic screeningnewborn screeningnext generation sequencingorganic acidemias

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Maternity and Children's Hospital, School of Medicine, Huaqiao University, Quanzhou 362021, China.
  • Center of Neonatal Disease Screening, Maternity and Children's Hospital, School of Medicine, Huaqiao University, Quanzhou 362021, China.
  • Xiamen Newborn Screening Center, Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361102, China.

ORCID-Profile: Yiming Lin, Xudong Wang

Förderung

  • Joint Funds for the Innovation of Science and Technology, Fujian province
  • Quanzhou Municipal Science and Technology Plan Project
  • Fujian Provincial Natural Science Foundation of China

Zitieren

APA

Lin, Y., Zhong, J., Peng, W., Zheng, F., & Wang, X. (2026). Incorporating Next-Generation Sequencing in Newborn Screening for Organic Acidemias. International Journal of Neonatal Screening, 12(1), 18. https://doi.org/10.3390/ijns12010018

Vancouver

Lin Y, Zhong J, Peng W, Zheng F, Wang X. Incorporating Next-Generation Sequencing in Newborn Screening for Organic Acidemias. International Journal of Neonatal Screening. 2026;12(1):18. doi:10.3390/ijns12010018

BibTeX
@article{Lin2026,
  author = {Lin, Yiming and Zhong, Jinping and Peng, Weilin and Zheng, Faming and Wang, Xudong},
  title = {Incorporating Next-Generation Sequencing in Newborn Screening for Organic Acidemias},
  journal = {International Journal of Neonatal Screening},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {18},
  doi = {10.3390/ijns12010018}
}
Kostenlos starten →